Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).
A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.
This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.
Publications found:
43,318
Sort by:
2016-2020 EU5 Pap Smear/HPV Market: Competitive Strategies, Country Volume and Sales Segment Forecasts
US$ 2,280.00
... , sales forecasts) $1,850. This report presents a detailed analysis of the Pap Smear/HPV testing market in Europe (France, Germany, Italy, Spain, UK), including clinical significance ... test volume and sales forecasts by country and market segment. The report examines market applications of DNA probes, biochips/microarrays, monoclonal antibodies ...
March 2016
240 pages
2016-2020 EU5 Respiratory Disease Market: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis-Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review
US$ 6,640.00
... provides analysis of the European respiratory disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. About this Report This report presents detailed analysis of the Respiratory Disease market in Europe (France ...
March 2016
335 pages
2016-2020 EU5 Sexually-Transmitted Disease (STD) Diagnostics Market: Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, Syphilis-Supplier Shares, Country Segment Volume and Sales Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation Review
US$ 6,320.00
... report from VPGMarketResearch. com provides analysis of the European sexually-transmitted disease testing market, including emerging tests, technologies, instrumentation, sales ... of leading suppliers. The report presents detailed analysis of the STD market in Europe (France, Germany, Italy, Spain, UK), Current ...
March 2016
318 pages
2016-2020 EU5 Therapeutic Drug Monitoring (TDM) Market: France, Germany, Italy, Spain, UK-Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts
US$ 5,200.00
... report from VPGMarketResearch. com provides a comprehensive analysis of the European therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market ...
March 2016
291 pages
2016-2020 World Echovirus Diagnostic Testing Market: Commercial Labs, Hospitals, Physician Offices, Public Health Labs-Competitive Strategies, Country Volume and Sales Segment Forecasts
US$ 3,480.00
... of the Echovirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Echovirus definition, ... addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Echovirus tests. Also ...
March 2016
193 pages
2016-2020 World Enterovirus Diagnostic Testing Market: Commercial Labs, Hospitals, Physician Offices, Public Health Labs-Competitive Strategies, Country Volume and Sales Segment Forecasts
US$ 3,480.00
... of the Enterovirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Enterovirus definition, ... addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Enterovirus tests. Also ...
March 2016
202 pages
Global Dendritic Cell Cancer Vaccine Market Outlook 2020
US$ 1,800.00
... Dendritic Cells New Vaccine Strategies That Exploit Dendritic Cells Biochemistry Dendritic Cell Cancer Vaccine Market & Clinical Insight Comparative Insight of Dendritic Cell Vaccines & Other Class of Vaccines Dendritic Cell Cancer Vaccine Pipeline by Country, Company, Indication & Phase Dendritic Cell Cancer ...
March 2016
213 pages
Epiomic Epidemiology Series: Stomach Cancer Forecast in 17 Major Markets 2016-2026
US$ 6,382.00
... Stomach Cancer include: History of stomach polyps or stomach lymphoma Family history of stomach cancer Family history of hereditary non-polyposis Colorectal cancer ... sourced from the proprietary Epiomic patient segmentation database. To ... patient registries, clinical trials and epidemiology studies. All of the ...
February 2016
66 pages
Breast Cancer: Update Bulletin [March 2016]
US$ 995.00
... with nab-paclitaxel for patients with metastatic triple- negative breast cancer (mTNBC); the US Food and Drug Administration (FDA) awarding ... of this expanded indication have on prescriptions of Ibrance and on those of Afinitor? Update Bulletins include expert insight and analysis based on FirstWord analyst re- ...
February 2016
Next generation cancer diagnostics - Global Market Outlook (2015-2022)
US$ 4,150.00
... . Growing incidence of oncology diseases is expected to boost the demand for next generation cancer diagnostic tests market. However, lack of sufficient reimbursement policies for novel ... the global next generation cancer diagnostics market growth over the forecast period. The largest segment of the global market for next generation cancer diagnostics is Blood-born cancers. Asia ...
February 2016
129 pages
Viral Molecular Diagnostics - Global Market Outlook (2015-2022)
US$ 4,150.00
... cost of molecular diagnostics are some of the key factors limiting the viral molecular diagnostics market growth. North America is the major market for the viral molecular diagnostics followed ... market for various viral molecular diagnostic tests, owing to growing incidence of viral infections in this market. Some of the key players in the global viral molecular diagnostics market include ...
February 2016
138 pages
Global Hepatitis C Virus (HCV) Market Report: 2016 Edition
US$ 800.00
Hepatitis C Virus (HCV) is an infection which affects the liver which may ... The key factors which are anticipated to drive HCV market include medical reimbursement because of the therapy ... are analyzed in depth. On the contention front, the global HCV market is reined by few major players namely Gilead Sciences, ...
February 2016
60 pages
Generic Oncology Drug Market - Industry Trends, Manufacturing Process, Plant Setup, Machinery, Raw Materials, Cost and Revenue
US$ 1,499.00
IMARC’s latest study “Generic Oncology Drug Market - Industry Trends, Manufacturing Process, Plant Setup, Machinery, Raw Materials, ... of the generic oncology market and who are the key players? What are the key success factors for generic oncology drug manufacturers? How are generic oncology drugs manufactured ...
February 2016
40 pages
A 39-Country Survey of the Transfusion Diagnostics Market-Volume and Sales Forecasts for 40 Tests, Supplier Shares, Competitive Strategies, Instrumentation Review, Emerging Technologies, Opportunities for Suppliers
US$ 38,000.00
This comprehensive 39-country report from VPGMarketResearch.com contains 1,025 pages, 387 tables ... of blood typing, grouping and infectious disease screening tests in major countries. Countries Analyzed in the Report Armenia, Australia, Austria, Belgium, Bulgaria, Canada ...
February 2016
1025 pages
A 33-Country Survey of the Tumor Marker Diagnostics Market: Sales Forecasts, Supplier Shares-Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains-Competitive Strategies, Emerging Opportunities
US$ 46,880.00
This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives ... and market shares of major cancer diagnostic product suppliers in major countries by individual test. Five-year test volume and sales forecasts ...
February 2016
1300 pages
A 33-Country Survey of the Virology and Bacteriology Testing Market: Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares, Competitive Strategies, Instrumentation Review, Emerging Technologies, Opportunities for Suppliers
US$ 51,600.00
This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables ... analysis not available from any other published source. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ... diagnostic products in major countries by test. Test and sales forecasts for 100 infectious disease diagnostic assays by country, individual test and market ...
February 2016
2100 pages
A 28-Country Survey of the Virology and Bacteriology Testing Market: Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares, Competitive Strategies, Instrumentation Review, Emerging Technologies, Opportunities for Suppliers
US$ 38,000.00
This unique 28-country survey from VPGMarketResearch.com contains over 1,700 pages, 625 tables ... analysis not available from any other published source. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ... diagnostic products in major countries by test. Test and sales forecasts for 100 infectious disease diagnostic assays by country, individual test and market ...
February 2016
1700 pages
Virology and Bacteriology Market 2020: Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts for 100 Tests, Innovative Technologies, Instrumentation Review, Emerging Opportunities
US$ 27,600.00
... . Geographic Coverage France Germany Italy Japan Spain UK US Market Segmentation Analysis Sales and market shares of major suppliers of infectious disease diagnostic products ... suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D. Worldwide Market Overview Estimated ...
February 2016
1954 pages
A 32-Country Survey of the European Transfusion Diagnostics Market-Volume and Sales Forecasts for 40 Tests, Supplier Shares, Competitive Strategies, Instrumentation Review, Emerging Technologies, Opportunities for Suppliers
US$ 26,000.00
This comprehensive 32-country report from VPGMarketResearch.com contains 830 pages, 287 tables ... of blood typing, grouping and infectious disease screening tests in major countries. Countries Analyzed in the Report Austria, Belgium, Bulgaria, Croatia, Czech Republic ...
February 2016
830 pages
Genomics In Cancer Care Market Analysis By Product (Instruments, Consumables, Services), By Application (Diagnostics, Personalized Medicine, Drug Discovery & Development, Research), By Technology (Genome Sequencing, PCR, Microarray, Nucleic Acid Extraction and Purification), By End-use (Hospitals, Research Institutes, Academic Institutes) And Segment Forecasts To 2022
US$ 5,950.00
Global genomics in cancer care market is expected to reach USD 9.22 billion by 2022, according to a new report by Grand View Research, Inc. Increasing prevalence of cancer coupled with adoption of next ...
February 2016
80 pages
RORgamma Modulators 2016: A comparative analysis of the landscape of RORgamma antagonists and agonists
US$ 1,018.00
RORgamma Modulators 2016: A comparative analysis of the landscape of RORgamma antagonists and agonists Retinoic acid-related orphan nuclear receptor gamma (RORgamma) is a hot, but difficult-to-drug target ... from start of a discovery program of RORgamma modulators until entry into human studies are calculated. The competitive landscape of RORgamma modulator development and discovery projects ...
February 2016
88 pages
Global Peptide Cancer Vaccine Market & Clinical Pipeline Insight
US$ 1,500.00
... Peptide Cancer Vaccine Need of Peptide Cancer Vaccines Clinical Trials Efficacy Study of Synthetic Peptide Analog Obtained From WT1 Oncoprotein Wide Spectrum Action of Peptide Cancer Vaccines against Major Cancer Global Peptide Cancer Vaccine Pipeline: 41 Vaccines Global Peptide Cancer Vaccine ...
February 2016
142 pages
Epiomic Epidemiology Series: Restless Leg Syndrome Forecast in 13 Major Markets 2016-2026
US$ 6,382.00
... information sourced from the proprietary Epiomic patient segmentation database. To generate ... form patient registries, clinical trials and epidemiology studies. All of the sources used ... conditions on Restless Legs Syndrome’s prevalent population. Identify sub-populations within Restless Legs Syndrome which ...
January 2016
52 pages
Global Peripheral Artery Disease (PAD) Market: Trends & Opportunities (2015-2020)
US$ 800.00
... entitled “Global Peripheral Artery Disease Market: Trends & Opportunities (2015-2020)”, analyses the global market for peripheral artery disease and the treatments available for it. The global peripheral artery disease market is analyzed by value, by number of people affected from PAD, PAD by prevalence ...
January 2016
61 pages
Epiomic Epidemiology Series: Pancreatic Cancer Forecast in 17 Major Markets 2016-2026
US$ 6,382.00
... Pancreatic Cancer include: • Obesity • Diabetes • Jaundice • Pancreatitis • Gallbladder enlargement This report is built using data and information sourced from the proprietary Epiomic ... to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the ...
January 2016
54 pages
Hepatitis C: Update Bulletin [February 2016]
US$ 995.00
... on the latest events that have the potential to shape the hepatitis C virus (HCV) treatment landscape. Topics covered include KOL ... if a short treatment regimen is attractive to KOLs. Key Questions Answered in this Update Bulletin: How do KOLs expect Merck & Co.’s Zepatier (elbasvir and grazoprevir) to be ...
January 2016
Global Cardiac Rhythm Management (CRM) Market Report: 2016 Edition
US$ 800.00
Cardiac rhythm management (CRM) is a well-established segment of the cardiology devices market. CRM majorly consists of devices such as implantable ... is expected. The report provides a comprehensive study of global cardiac rhythm management (CRM) market and also the regional markets. The competition in ...
January 2016
48 pages
Epiomic Epidemiology Series: Crohn's Disease Forecast in 8 Major Markets 2016-2026
US$ 6,382.00
... Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Crohn’s Disease in 8 Major Markets Crohn's disease, also known as regional enteritis, is a type of chronic inflammatory bowel disease. While it may affect ... on the impact from specific co-morbid conditions on Crohn’s disease’s prevalent population. Identify sub-populations within Crohn’s disease which require treatment. Gain an understanding of the ...
January 2016
48 pages
Epiomic Epidemiology Series: Neuropathic Pain Forecast in 15 Major Markets 2016-2026
US$ 6,382.00
... Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Neuropathic Pain in 15 Major Markets Neuropathic pain is generally defined as chronic pain resulting from injury to the nervous system. Neuropathic pain is caused by other ... on the impact from specific co-morbid conditions on Neuropathic Pain’s prevalent population. Identify sub-populations within Neuropathic Pain which require treatment. Gain an understanding of the ...
January 2016
56 pages
